⌘K

Login Start Free

Home/Insiders/Calias Pericles

CP

SEC Insider//CIK 0001746282

Calias Pericles

CIK 00017462821 companyBALTIMORE, MD

Transactions

7

Companies

1

Filings

6

CIK

0001746282

Recent Transactions

7 trades

Purchase
Avalo Therapeutics, Inc.$AVTX
Common Stock
2019-12-10$2.85/sh+2,913→ 52,462 total
Tax Payment
Avalo Therapeutics, Inc.$AVTX
Common Stock
2019-07-16$4.90/sh−3,246→ 49,216 total
Purchase
Avalo Therapeutics, Inc.$AVTX
Common Stock
2019-06-10$2.85/sh+4,549→ 49,549 total
Award
Avalo Therapeutics, Inc.$AVTX
Common Stock
2019-05-24+45,000→ 45,000 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2019-05-24+25,000→ 25,000 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2019-04-01+175,000→ 175,000 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2018-07-16+80,000→ 80,000 total

Companies

1

Avalo Therapeutics, Inc.
Chief Scientific Officer
$AVTX

Recent Filings

6

Address

C/O CERECOR INC. 400 EAST PRATT STREET, SUITE 606

BALTIMORE, MD, 21202

View on SEC.gov